2021
Misoprostol for labour induction
Kumar N, Haas D, Weeks A. Misoprostol for labour induction. Best Practice & Research Clinical Obstetrics & Gynaecology 2021, 77: 53-63. PMID: 34607746, DOI: 10.1016/j.bpobgyn.2021.09.003.Peer-Reviewed Original ResearchConceptsVaginal birthVaginal misoprostolOral misoprostolCaesarean sectionRate of caesarean sectionCaesarean section rateFoetal heart rate changesPerinatal adverse eventsUterine hyperstimulationBalloon catheterLabor inductionSection rateEffective induction methodMisoprostolNeonatal complicationsHeart rate changesNo significant differenceRandomised comparisonAdverse eventsSide effectsBirthSignificant differenceHyperstimulationCatheterDinoprostone
2013
Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
O’Brien T, Kalmin M, Harralson A, Clark A, Gindoff I, Simmens S, Frankfurter D, Gindoff P. Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reproductive Biology And Endocrinology 2013, 11: 71. PMID: 23883350, PMCID: PMC3727944, DOI: 10.1186/1477-7827-11-71.Peer-Reviewed Original ResearchConceptsControlled ovarian hyperstimulationResponse to COHOvarian hyperstimulationLuteinizing hormone/chorionic gonadotropin receptorOvarian hyperstimulation syndromeDay 3 FSH levelsOHSS riskHyperstimulation syndromeLinkage disequilibriumIVF centerCarrier statusOHSSHyperstimulationPredictive of outcomeGenetic variationRecessive allelesResultsIncreasing ageFSH levelsProspective studyGonadotropin receptorsFunctional polymorphismsIncreased riskBackgroundThe aimDay 3C variantWhy we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone
Toner JP, Seifer DB. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimüllerian hormone. Fertility And Sterility 2013, 99: 1825-1830. PMID: 23548941, DOI: 10.1016/j.fertnstert.2013.03.001.Peer-Reviewed Original Research
2008
Serum FSH monitoring improves decision making in women undergoing controlled ovarian hyperstimulation with letrozole and follicle stimulating hormone
Oktay K, Kim J, Barad D, Gleicher N, Blanchette H. Serum FSH monitoring improves decision making in women undergoing controlled ovarian hyperstimulation with letrozole and follicle stimulating hormone. Fertility And Sterility 2008, 90: s183-s184. DOI: 10.1016/j.fertnstert.2008.07.779.Peer-Reviewed Original Research
2007
Prospective follow up of children born following controlled ovarian hyperstimulation with combined continuous letrozole-gonadotropin protocol
Elassar A, Shahin G, Oktay K. Prospective follow up of children born following controlled ovarian hyperstimulation with combined continuous letrozole-gonadotropin protocol. Fertility And Sterility 2007, 88: s338-s339. DOI: 10.1016/j.fertnstert.2007.07.1130.Peer-Reviewed Original ResearchOvarian hyperstimulationHyperstimulation
2006
O-229 In vitro maturation increases the number of oocytes and embryos cryopreserved from cancer patients undergoing controlled ovarian hyperstimulation (COH) prior to chemotherapy
Oktay K, Azim A, Sahin G, Yin H, Zaninovic N, Veeck-Gosden L. O-229 In vitro maturation increases the number of oocytes and embryos cryopreserved from cancer patients undergoing controlled ovarian hyperstimulation (COH) prior to chemotherapy. Fertility And Sterility 2006, 86: s98-s99. DOI: 10.1016/j.fertnstert.2006.07.261.Peer-Reviewed Original Research
2005
Comparison of the Luteal Phase after Pituitary Suppression With GnRH-Agonist Versus GnRH Antagonist in Controlled Ovarian Hyperstimulation
Willman S, Kliman H. Comparison of the Luteal Phase after Pituitary Suppression With GnRH-Agonist Versus GnRH Antagonist in Controlled Ovarian Hyperstimulation. Fertility And Sterility 2005, 84: s308. DOI: 10.1016/j.fertnstert.2005.07.806.Peer-Reviewed Original Research
2004
Estradiol production during controlled ovarian hyperstimulation correlates with the risk of pregnancy loss in pregnancies achieved after IVF-ET
Mitwally M, Abdel-Razeq S, O'Gavaghan H, Crickard K, Suilivan M. Estradiol production during controlled ovarian hyperstimulation correlates with the risk of pregnancy loss in pregnancies achieved after IVF-ET. Fertility And Sterility 2004, 82: s198. DOI: 10.1016/j.fertnstert.2004.07.523.Peer-Reviewed Original ResearchEstradiol production during controlled ovarian hyperstimulation correlates with the birth weight in pregnancies achieved after in vitro fertilization
Mitwally M, Abdel-Razeq S, Suilivan M, Crickard K. Estradiol production during controlled ovarian hyperstimulation correlates with the birth weight in pregnancies achieved after in vitro fertilization. Fertility And Sterility 2004, 82: s50-s51. DOI: 10.1016/j.fertnstert.2004.07.131.Peer-Reviewed Original Research
2003
Endometrial HOXA10 expression after controlled ovarian hyperstimulation with recombinant follicle-stimulating hormone
Taylor HS, Daftary GS, Selam B. Endometrial HOXA10 expression after controlled ovarian hyperstimulation with recombinant follicle-stimulating hormone. Fertility And Sterility 2003, 80: 839-843. PMID: 14505762, DOI: 10.1016/s0015-0282(03)00985-3.Peer-Reviewed Original ResearchMeSH KeywordsAdultEmbryo ImplantationEndometriumEstradiolFemaleFertility Agents, FemaleFollicle Stimulating HormoneGonadotropin-Releasing HormoneHomeobox A10 ProteinsHomeodomain ProteinsHormone AntagonistsHumansLeuprolideOvulation InductionProspective StudiesRecombinant ProteinsReverse Transcriptase Polymerase Chain ReactionRNATumor Cells, CulturedConceptsEndometrial HOXA10 expressionOvarian hyperstimulationRecombinant FSHReverse transcriptase-polymerase chain reactionGnRH agonistGnRH antagonistHOXA10 expressionFertile controlsRecombinant follicle-stimulating hormoneCycle day 21Pipelle endometrial biopsyFollicle-stimulating hormoneQuantitative reverse transcriptase-polymerase chain reactionTranscriptase-polymerase chain reactionAcademic medical centerDose-dependent mannerEndometrial biopsyEndometrial receptivityProspective studyIshikawa cellsMedical CenterHyperstimulationMAIN OUTCOMEFSHDay 21
1998
Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury
Grady T, Mah’Moud M, Otani T, Rhee S, Lerch MM, Gorelick FS. Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury. American Journal Of Physiology 1998, 275: g1010-g1017. PMID: 9815031, DOI: 10.1152/ajpgi.1998.275.5.g1010.Peer-Reviewed Original ResearchConceptsPancreatic acinar cellsAcinar cellsCellular injuryForms of pancreatitisAcinar cell injuryTrypsinogen activation peptideSecretagogue treatmentPathological activationCell injuryInjuryIsolated aciniHyperstimulationBombesin treatmentPancreatic aciniTrypsinogen processingImmunofluorescence studiesBombesin stimulationAciniCA1TreatmentDigestive zymogensActivationCellsZymogen activationZymogen processing
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply